tradingkey.logo

Lantheus Holdings Inc

LNTH
66.351USD
-0.269-0.40%
交易中 美东报价延迟15分钟
4.40B总市值
26.93市盈率 TTM

Lantheus Holdings Inc

66.351
-0.269-0.40%

关于 Lantheus Holdings Inc 公司

Lantheus Holdings, Inc. is a radiopharmaceutical-focused company engaged in delivering science to enable clinicians to find, fight and follow diseases to deliver patient outcomes. The Company classifies its products in three categories: Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships. Radiopharmaceutical Oncology diagnostics and therapeutics help healthcare professionals (HCPs) find, fight and follow cancer, with a focus on prostate cancer. Precision Diagnostic products assist HCPs to find and follow diseases, with a focus on cardiology. Strategic Partnerships focus on enabling precision medicine through the use of biomarker solutions, digital solutions, and radiotherapeutic platforms. Its commercial products include PYLARIFY, DEFINITY, TechneLite, Neuraceq, and others. Its clinical candidates include LNTH-2404, NAV-4694, and PNT2002, among others. The Neuraceq (florbetaben F18 injection) is an F-18 PET imaging agent for Alzheimer’s disease.

Lantheus Holdings Inc简介

公司代码LNTH
公司名称Lantheus Holdings Inc
上市日期Jun 25, 2015
CEOMarkison (Brian A)
员工数量808
证券类型Ordinary Share
年结日Jun 25
公司地址331 Treble Cove Road
城市NORTH BILLERICA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编01862
电话19786718001
网址https://www.lantheus.com/
公司代码LNTH
上市日期Jun 25, 2015
CEOMarkison (Brian A)

Lantheus Holdings Inc公司高管

名称
名称/职务
职务
持股
持股变动
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
599.01K
+2.44%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
232.42K
+35.31%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-31.55%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
35.74K
+7.64%
Ms. Julie H. Mchugh
Ms. Julie H. Mchugh
Lead Independent Director
Lead Independent Director
25.96K
-16.67%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
23.36K
+10.09%
Ms. Minnie Baylor-Henry, J.D.
Ms. Minnie Baylor-Henry, J.D.
Independent Director
Independent Director
9.90K
+34.47%
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Dr. Phuong Khanh (P. K.) Morrow, M.D.
Independent Director
Independent Director
3.10K
+450.62%
Mr. Samuel R. (Sam) Leno
Mr. Samuel R. (Sam) Leno
Independent Director
Independent Director
--
--
Ms. Jamie Spaeth
Ms. Jamie Spaeth
Chief People Officer
Chief People Officer
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Ms. Mary Anne Heino
Ms. Mary Anne Heino
Executive Chairman of the Board, Interim Executive Officer
Executive Chairman of the Board, Interim Executive Officer
599.01K
+2.44%
Mr. Brian A. Markison
Mr. Brian A. Markison
Chief Executive Officer, Director
Chief Executive Officer, Director
232.42K
+35.31%
Dr. Jean-Claude Provost, M.D.
Dr. Jean-Claude Provost, M.D.
Chief Scientific Officer
Chief Scientific Officer
38.84K
-31.55%
Dr. James H. (Jim) Thrall
Dr. James H. (Jim) Thrall
Independent Director
Independent Director
35.74K
+7.64%
Ms. Julie H. Mchugh
Ms. Julie H. Mchugh
Lead Independent Director
Lead Independent Director
25.96K
-16.67%
Dr. Gerard Ber, Ph.D.
Dr. Gerard Ber, Ph.D.
Independent Director
Independent Director
23.36K
+10.09%

收入明细

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
业务USD
名称
营收
占比
PYLARIFY
250.64M
0.00%
DEFINITY
83.94M
0.00%
TechneLite
24.98M
0.00%
Strategic partnerships and other
11.59M
0.00%
Other precision diagnostics
6.89M
0.00%
由于公司未披露,未能获取相关数据
业务
地区
业务USD
名称
营收
占比
PYLARIFY
250.64M
0.00%
DEFINITY
83.94M
0.00%
TechneLite
24.98M
0.00%
Strategic partnerships and other
11.59M
0.00%
Other precision diagnostics
6.89M
0.00%

股东统计

更新时间: 11月16日 周日
更新时间: 11月16日 周日
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.00%
The Vanguard Group, Inc.
10.44%
Janus Henderson Investors
10.08%
Morgan Stanley & Co. LLC
5.55%
Farallon Capital Management, L.L.C.
5.24%
其他
57.69%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
11.00%
The Vanguard Group, Inc.
10.44%
Janus Henderson Investors
10.08%
Morgan Stanley & Co. LLC
5.55%
Farallon Capital Management, L.L.C.
5.24%
其他
57.69%
股东类型
持股股东
占比
Investment Advisor
53.54%
Investment Advisor/Hedge Fund
36.56%
Research Firm
8.90%
Hedge Fund
8.13%
Individual Investor
2.40%
Pension Fund
1.80%
Bank and Trust
0.94%
Sovereign Wealth Fund
0.77%
Family Office
0.09%

机构持股

更新时间: 10月5日 周日
更新时间: 10月5日 周日
报告期
机构数
持股数
持股占比
持股变动
2025Q3
1018
78.96M
119.07%
-8.67M
2025Q2
1039
82.20M
120.88%
-4.84M
2025Q1
1066
83.20M
120.27%
-2.89M
2024Q4
1033
78.65M
114.86%
-4.64M
2024Q3
1003
73.69M
106.06%
-7.92M
2024Q2
959
71.82M
103.63%
-10.29M
2024Q1
912
71.21M
103.87%
-11.25M
2023Q4
868
73.50M
107.32%
-9.24M
2023Q3
828
74.80M
109.31%
-3.81M
2023Q2
790
72.85M
106.61%
-3.94M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
7.50M
11.03%
-294.68K
-3.78%
Jun 30, 2025
The Vanguard Group, Inc.
6.82M
10.03%
-163.58K
-2.34%
Jun 30, 2025
Janus Henderson Investors
6.94M
10.21%
+677.11K
+10.81%
Jun 30, 2025
Farallon Capital Management, L.L.C.
3.32M
4.88%
-3.41M
-50.67%
Aug 20, 2025
Fidelity Management & Research Company LLC
4.13M
6.08%
+1.96M
+90.51%
Jun 30, 2025
State Street Investment Management (US)
2.56M
3.76%
-76.88K
-2.92%
Jun 30, 2025
Geode Capital Management, L.L.C.
1.78M
2.61%
-532.00
-0.03%
Jun 30, 2025
Dimensional Fund Advisors, L.P.
1.38M
2.03%
+4.59K
+0.33%
Jun 30, 2025
Reinhart Partners, LLC
1.40M
2.06%
+197.72K
+16.40%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
State Street SPDR S&P Health Care Equipment ETF
1.96%
Invesco S&P MidCap 400 GARP ETF
1.69%
First Trust Small Cap US Equity Select ETF
1.07%
VictoryShares Small Cap Free Cash Flow ETF
0.93%
Invesco S&P MidCap 400 Pure Growth ETF
0.74%
Distillate Small/Mid Cash Flow ETF
0.66%
Pacer US Small Cap Cash Cows ETF
0.56%
Gotham 1000 Value ETF
0.5%
Invesco S&P MidCap Quality ETF
0.47%
Pacer US Cash Cows Growth ETF
0.47%
查看更多
State Street SPDR S&P Health Care Equipment ETF
占比1.96%
Invesco S&P MidCap 400 GARP ETF
占比1.69%
First Trust Small Cap US Equity Select ETF
占比1.07%
VictoryShares Small Cap Free Cash Flow ETF
占比0.93%
Invesco S&P MidCap 400 Pure Growth ETF
占比0.74%
Distillate Small/Mid Cash Flow ETF
占比0.66%
Pacer US Small Cap Cash Cows ETF
占比0.56%
Gotham 1000 Value ETF
占比0.5%
Invesco S&P MidCap Quality ETF
占比0.47%
Pacer US Cash Cows Growth ETF
占比0.47%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Lantheus Holdings Inc的前五大股东是谁?

Lantheus Holdings Inc 的前五大股东如下:
BlackRock Institutional Trust Company, N.A.持有股份:7.50M,占总股份比例:11.03%。
The Vanguard Group, Inc.持有股份:6.82M,占总股份比例:10.03%。
Janus Henderson Investors持有股份:6.94M,占总股份比例:10.21%。
Farallon Capital Management, L.L.C.持有股份:3.32M,占总股份比例:4.88%。
Fidelity Management & Research Company LLC持有股份:4.13M,占总股份比例:6.08%。

Lantheus Holdings Inc的前三大股东类型是什么?

Lantheus Holdings Inc 的前三大股东类型分别是:
BlackRock Institutional Trust Company, N.A.
The Vanguard Group, Inc.
Janus Henderson Investors

有多少机构持有Lantheus Holdings Inc(LNTH)的股份?

截至2025Q3,共有1018家机构持有Lantheus Holdings Inc的股份,合计持有的股份价值约为78.96M,占公司总股份的119.07%。与2025Q2相比,机构持股有所增加,增幅为-1.81%。

哪个业务部门对Lantheus Holdings Inc的收入贡献最大?

在FY2025Q2,PYLARIFY业务部门对Lantheus Holdings Inc的收入贡献最大,创收250.64M,占总收入的--%。
KeyAI